Zhitong Finance App News, Placo (603566.SH) issued an announcement. Recently, the company's holding subsidiary, Zhongpu Biopharmaceutical Co., Ltd. (hereinafter referred to as “Zhongpu Biotech”) received approval documents for the two products “swine foot and mouth disease O type O, type A, and South Africa type 1 trivalent inactivated vaccine” from the Ministry of Agriculture and Rural Affairs.

The approval for production of the foot-and-mouth disease vaccine containing South Africa's type 1 foot-and-mouth disease vaccine will further enrich the company's foot-and-mouth disease vaccine product matrix, improve the layout of major animal disease prevention and control products, and enhance domestic prevention and control measures for currently prevalent strains; at the same time, the company will speed up the completion of pre-marketing tasks such as batch issuance, and rely on the rapid implementation of the existing production and marketing system, which is expected to enhance the profitability and market competitiveness of Zhongpu Biotech and bring new performance growth points to the company.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.